Insights On Pharmaceutical Production

  1. Viral Vector Development, Manufacturing, And Process Intensification 10/30/2019

    An overview of the tools and technologies available for development of viral vectors and to provide insights into techniques that viral vector manufacturers can use to intensify their production processes.

  2. Telltale Signs You’re With The Wrong CDMO 4/27/2020

    Is your CDMO an asset or a hindrance? This article explores 10 red flags that signal your parter isn't carrying its weight on your journey to commercialization.

  3. High Potency Drug Manufacturing: Molecule To Market 8/5/2020

    The pharmaceutical landscape continues to evolve, with much R&D focusing on more specialized medicines. As the biological activity and specificity of the API increases, dosage strengths decrease – resulting in increased potency of the APIs in terms of occupational handling for drug product manufacture. This paper examines the process of successful high potency drug manufacturing and delivery to market.

  4. Fluid Bed Granulation And Melt Granulation In Pharma Manufacturing 3/19/2019

    Affording superior reproducibility and control than other granulation techniques, fluid bed granulation and melt granulation can be tightly regulated to produce uniform material with a specified particle size.

  5. Is Your Partner Prepared For Your Scale-Up Challenges? 6/26/2019

    Most early-stage companies are not equipped with the means necessary for successful scale-up and commercialization, it is critical you find a partner that can help you overcome the challenges.

  6. The Future Of Highly Potent API Manufacturing - Lonza Perspective 5/7/2020

    Highly potent active pharmaceutical ingredients (HPAPIs) represent an increasing fraction of new compounds in pharmaceutical pipelines today. Flexible and phase-appropriate infrastructure is needed to bring the next innovative medicines based on these challenging compounds from concept to commercialization. Thispresentation describes Lonza's HPAPI "manufacturing 4.0" investments and the company's innovative capabilities.

  7. Continuous Or Batch: Deciding On The Best Solution For Your Oral Solid Dose Product 4/21/2020

    Gaining a better understanding of continuous manufacturing and its fitness for your OSD product could secure more control over the quality and safety of your product and, ultimately, the future of its success.

  8. Is Your CMO Ready For Serialization And Aggregation? 3/20/2019

    While some are waiting for mandates for traceability, serialization, and aggregation, others are recognizing the inevitability of these strategies. Does your CMO have a dedicated traceability operation in place?

  9. Embedding Your Drug Strategy Within A Solid Foundation For Success 3/24/2020

    This white paper looks at the set of trends influencing pharmaceutical development and manufacturing strategy today, and how these drivers are influencing new business models with outsourced partners. 

  10. Ensuring Strength And Flexibility Of Single-Use Bags In All Applications 3/18/2019

    The costs are high when leakage occurs during steps that are critical to patient safety. Read how the robustness of Sartorius films makes them safe and easy to use for all process steps and applications.